AbCellera Biologics Inc. (ABCL) Form 8-K — Jul 6, 2026
AbCellera Biologics Inc. appointed Dr. Lynn Seely, M.D. to its Board of Directors as a new Class III director effective June 30, 2026.
Price after filing
1 day: -2.3%7 days: -17.2%30 days: -22.6%
Close on the filing date to close N calendar days later (from $7.87). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.